Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (FDA-approved semaglutide) has demonstrated significant weight loss outcomes in clinical research, with participants achieving reductions ranging from 15% to 22% of their starting body weight. However, actual results depend on multiple factors including genetic predisposition, adherence to treatment, dietary habits, and physical activity levels. Understanding realistic expectations helps patients make informed decisions about GLP-1 therapy.

Clinical Trial Results: What the Data Shows

The STEP trials, which examined semaglutide efficacy for weight loss, enrolled over 4,500 adults across multiple studies. Participants receiving the highest dose (2.4 mg weekly) lost an average of 22% of their body weight—approximately 15 pounds per month during the first 8–12 weeks, then tapering as the body adapts. Placebo groups lost only 2–3% on average, demonstrating that semaglutide produces meaningful weight reduction beyond diet and exercise alone.

Weight loss typically follows a pattern: rapid initial loss during dose escalation (weeks 1–16), followed by steady decline through maintenance phases (weeks 16–68). By week 68, most participants had reached a plateau, meaning their bodies stabilized at a lower weight. These results held across diverse populations, including individuals with obesity, type 2 diabetes, and cardiovascular disease.

Why Individual Weight Loss Results Vary

Genetic factors influence how efficiently your body responds to GLP-1 medications. Variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect appetite signaling and metabolic rate. Two people taking identical doses may experience different hunger reduction, satiety duration, and weight loss speed because their genetic pathways process semaglutide differently. PlexusDx Precision Peptide Genetic Test identifies 14 peptide pathways and 150+ genetic insights to predict your personalized response.

Lifestyle factors account for 40–60% of weight loss outcomes. Participants who combined semaglutide with calorie reduction, consistent physical activity, and adequate sleep lost significantly more than those relying on medication alone. Adherence to weekly injections also matters—missed doses or inconsistent injection timing reduces effectiveness. Age, starting weight, baseline metabolism, and stress levels further influence how quickly and sustainably you lose weight.

Semaglutide vs. Tirzepatide: Comparing Weight Loss Outcomes

Tirzepatide (Zepbound) targets two hormone pathways (GLP-1 and GIP), while semaglutide targets GLP-1 alone. SURMOUNT trials showed tirzepatide produced 20–22% weight loss at the highest dose—slightly more than semaglutide in some subgroups. However, semaglutide is typically better tolerated with fewer gastrointestinal side effects, making it the preferred choice for patients sensitive to nausea. Individual genetic profiles determine whether dual-mechanism therapy or single-pathway treatment yields better results.

Cost considerations matter: PlexusDx compounded semaglutide injection starts at $149/month, while tirzepatide begins at $249/month. Your dose may need to go up. Your price won't. Both are available without insurance, HSA/FSA eligible, and shipped to all 50 states from licensed 503A compounding pharmacies.

Maintaining Weight Loss After Reaching Your Goal

Clinical evidence shows that stopping semaglutide typically results in weight regain within 6–12 months if dietary and exercise habits don't change. Participants in STEP trials who discontinued treatment regained approximately 50% of lost weight by one year. This reflects semaglutide's mechanism: it suppresses appetite and hunger signals, and stopping medication removes that support. Successful long-term maintenance requires sustained lifestyle changes alongside continued treatment or periodic medication use.

PlexusDx patients often benefit from ongoing genetic insights paired with medication continuity. The Precision Peptide Genetic Test ($99 add-on after month one) reveals your unique peptide predispositions, allowing providers to optimize dosing and combination therapies. Many patients achieve their goal weight within 6–12 months, then transition to a lower maintenance dose or alternate protocol to sustain results while managing cost and side effects.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose on semaglutide?

Average weight loss ranges from 15–22% of body weight over 68 weeks, depending on starting weight, genetics, dose, and lifestyle adherence. Some patients lose 2–3 pounds per week early on; others lose 1 pound weekly. PlexusDx Precision Peptide Genetic Test helps predict your individual response by analyzing GLP1R, GIPR, FTO, and MC4R variants that influence weight loss potential.

How fast do you lose weight on Wegovy or compounded semaglutide?

Weight loss accelerates during the dose escalation phase (weeks 1–16), with some patients losing 15 pounds per month. After reaching the maintenance dose (2.4 mg), loss continues but at a slower rate—typically 1–2 pounds per week through week 68. Speed depends on your starting weight, metabolism, and how strictly you follow dietary recommendations alongside treatment.

Is compounded semaglutide as effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and demonstrates equivalent clinical outcomes in real-world use. PlexusDx sources from certified 503A compounders, ensuring pharmaceutical-grade quality at a fraction of brand-name cost—starting at $149/month compared to $900+ for Wegovy brand. Effectiveness depends on consistent dosing and lifestyle factors, not the source of compounding.

What happens to weight loss results if I stop taking semaglutide?

Most patients regain 50% of lost weight within 6–12 months of stopping semaglutide if dietary and exercise habits don't change. Clinical trials show sustained weight loss only occurs with continued treatment or permanent lifestyle modification. Discuss long-term maintenance strategies with your PlexusDx provider to determine whether ongoing therapy, periodic dosing, or alternative protocols best fit your goals.

How does my genetics affect weight loss on GLP-1 medication?

Variants in GLP1R, GIPR, FTO, and MC4R genes influence appetite signaling, metabolic rate, and satiety response to semaglutide. The PlexusDx Precision Peptide Genetic Test ($99 add-on) maps 14 peptide pathways and 150+ genetic insights to reveal your unique predispositions, allowing your provider to optimize dose, combination therapy, and lifestyle recommendations for maximum weight loss potential.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves